MarketInOut Stock Screener Log In | Sign Up
 

Bioventus Inc Cl A

NASDAQ • Healthcare • Medical Devices • Quote as of 10/06/2026 13:29
Bioventus Inc Cl A stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization923.49 mln
Float47.25 mln
Earnings Date11/10/2026

EPS

0.78
Moderate

P / E

16.97
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.68
Likely reliable

Relative Strength

35 / 100
Underperforming

Debt / Equity

1.16
Elevated leverage

Business Description

Bioventus Inc., founded in 2011 and based in Durham, North Carolina, develops and sells medical products designed to reduce pain, support bone healing, and treat conditions affecting muscles, joints, and the spine. Its offerings range from joint injections and bone grafts to surgical tools and nerve stimulation devices, serving patients across the United States and in international markets. The company distributes its products through hospitals, physicians, and various reseller channels.

Key Fundamentals

EPS0.78
P/E16.97
ROE29.32
RPS8.65
ROIC11.46
ROA7.97
Interest Cover3.09
EBITDA, mln104
EV / EBITDA11.95
EV / EBIT21.19
Revenue, mln582
EV / Revenue2.13

Quote Details

Last 13.23
Change -0.29 (-2.14%)
Open 13.50
Volume 95,380
Turnover 1,261,877
Average Volume 442,357

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio2.95
Current Ratio1.69
Price / Book3.35
Price / Cash Flow9.47
Price / Free Cash Flow10.11
Debt / Equity1.16
Price / Sales1.68
PEG Ratio1.53

Financial Strength

Altman Z-Score2.17
Piotroski F-Score 8 / 9
Beneish M-Score-2.68
Price to Intrinsic Value2.07
Short Ratio5.37
Short % of Float6.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.5% 14 / 100   
1 Month -5.97% 33 / 100   
2 Months 40.15% 95 / 100   
6 Months 49.66% 92 / 100   
1 Year 88.46% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us